COSM250117C2500
- 0.05
- 0.000.00%
Cosmos Health Newsroom
Cosmos Health Strengthens R&D Leadership and Innovation With the Appointment of Professor Dimitrios Trafalis, MD, as Head of Oncology
Healthcare and Medical Simulation Market Size Expected to Reach USD 7.04 Bn by 2034
Cosmos Health CEO Greg Siokas and CFO George Terzis Collectively Increase Stake by 343,000 Shares Valued at $200,000
Cosmos Health Offering Stock, Together With Warrants
Taglich Brothers Releases Updated Coverage on Cosmos Health: Projects Positive EPS for 2025 and Sets $3 Price Target, Nearly 300% Above Current Share Price
Biden Proposes Medicare, Medicaid Coverage of Obesity Drugs
Cosmos Health Integrates Bitcoin and Ethereum as Treasury Reserve Assets
Cosmos Health Third Quarter 2024 Earnings: Misses Expectations
Earnings Flash (COSM) COSMOS HEALTH Reports Q3 Revenue $12.4M
Express News | Cosmos Health Q3 Revenue USD 12.41 Million
Express News | Cosmos Health Q3 Adjusted Net Income USD -880 Thousand
Express News | Cosmos Health Q3 Adjusted Ebitda USD -700 Thousand
Express News | Cosmos Health Q3 EBIT USD -2.24 Million
Express News | Cosmos Health Q3 Operating Expenses USD 3.45 Million
Cosmos Health | 10-Q: Q3 2024 Earnings Report
Express News | Cosmos Health: On November 6, Co Receives Notice for Minimum Bid Price Non-Compliance
Cosmos Health Sees FY27 Revenue To Increase By 163%, From $59.35M In 2024 To $155.80M In 2027; Gross Profit To Grow By 653%, From $6.25M In 2024 To $47.06M In 2027; Gross Profit Margin To Expand By 1,970 Basis Points, From 10.50% In 2024 To 30.20% In...
Cosmos Health Issues Letter to Shareholders
Cosmos Health's Subsidiary CosmoFarm Achieves Record Revenue, Up 8.62% to $43 Million YTD 2024, With Gross Profit Rising 21%
Cosmos Health Files Secondary Offering of Shares